Sleep and circadian biomarkers of postoperative delirium (SLEEP-POD): protocol for a prospective and observational cohort study

E Sugg, E Gleeson, SN Baker, P Li, C Gao, A Mueller… - BMJ open, 2024 - bmjopen.bmj.com
Introduction Surgical patients over 70 experience postoperative delirium (POD) complications
in up to 50% of procedures. Sleep/circadian disruption has emerged as a potential risk …

Associations of rest-activity rhythm disturbances with stroke risk and post-stroke adverse outcomes

L Gao, X Zheng, SN Baker, P Li, FAJL Scheer… - medRxiv, 2023 - medrxiv.org
Background Almost all biological and disease processes are influenced by circadian clocks
and display ∼24-hour rhythms. Disruption of these rhythms may be an important novel risk …

Tobacco use and cancer‐related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study

…, AM Palmer, LM Fucito, EM Graboyes, NL Baker… - Cancer, 2023 - Wiley Online Library
Background Understanding the relationship between tobacco use and symptom burden
may inform tobacco treatment interventions tailored to the needs of individuals with cancer. …

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

…, G Babbage, K Baillie, M Baker, N Baker, P Baker… - The Lancet, 2020 - thelancet.com
Background The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
might be curtailed by vaccination. We assessed the safety, reactogenicity, and …

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa …

…, C Bailey, KF Baker, M Baker, N Baker, P Baker… - The Lancet, 2021 - thelancet.com
Background A safe and efficacious vaccine against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of …

[HTML][HTML] Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind …

…, EH Arbe-Barnes, M Baker, N Baker, P Baker… - The Lancet, 2020 - thelancet.com
Background Older adults (aged ≥70 years) are at increased risk of severe disease and
death if they develop COVID-19 and are therefore a priority for immunisation should an …

[HTML][HTML] Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a …

…, C Bailey, KF Baker, M Baker, N Baker, P Baker… - The Lancet, 2021 - thelancet.com
Background The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency
use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, …

Chlorophyll fluorescence: a probe of photosynthesis in vivo

NR Baker - Annu. Rev. Plant Biol., 2008 - annualreviews.org
The use of chlorophyll fluorescence to monitor photosynthetic performance in algae and
plants is now widespread. This review examines how fluorescence parameters can be used to …

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a …

…, K Davies, P Ambrose, L Hitchins, N Baker… - The Lancet, 2021 - thelancet.com
Background Use of heterologous prime-boost COVID-19 vaccine schedules could facilitate
mass COVID-19 immunisation. However, we have previously reported that heterologous …

[PDF][PDF] Reduced neutralization of SARS-CoV-2 B. 1.1. 7 variant by convalescent and vaccine sera

…, N Baker, I Shaik, HE Humphries, K Godwin, N Gent… - Cell, 2021 - cell.com
SARS-CoV-2 has caused over 2 million deaths in little over a year. Vaccines are being
deployed at scale, aiming to generate responses against the virus spike. The scale of the …